{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T21:15:21Z","timestamp":1783458921637,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2024GXNSFDA999003"],"award-info":[{"award-number":["2024GXNSFDA999003"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460697"],"award-info":[{"award-number":["82460697"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173736"],"award-info":[{"award-number":["82173736"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360698"],"award-info":[{"award-number":["82360698"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42376112"],"award-info":[{"award-number":["42376112"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["GUIKE AA25069003"],"award-info":[{"award-number":["GUIKE AA25069003"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","award":["82320108019"],"award-info":[{"award-number":["82320108019"]}],"id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.neuropharm.2026.111070","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:58:52Z","timestamp":1781207932000},"page":"111070","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Identification of key determinants in \u03b1 subunit for \u03b1-conotoxin [D1G, \u0394Q14]LvIC selectively targeting rat \u03b16\/\u03b13\u03b24 nicotinic acetylcholine receptor"],"prefix":"10.1016","volume":"298","author":[{"given":"Baixue","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zepei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongting","family":"Zhangsun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4936-8637","authenticated-orcid":false,"given":"Jinpeng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sulan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8016","key":"10.1016\/j.neuropharm.2026.111070_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.neuropharm.2026.111070_bib2","doi-asserted-by":"crossref","first-page":"5815","DOI":"10.1021\/cr400401e","article-title":"Discovery, synthesis, and structure-activity relationships of conotoxins","volume":"114","author":"Akondi","year":"2014","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111070_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1074\/jbc.M406281200","article-title":"Alpha-conotoxin BuIA, a novel peptide from Conus bullatus, distinguishes among neuronal nicotinic acetylcholine receptors","volume":"280","author":"Azam","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111070_bib6","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1096\/fj.10-166272","article-title":"\u03b1-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between \u03b16\u00df4 and \u03b16\u00df2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release","volume":"24","author":"Azam","year":"2010","journal-title":"FASEB J."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111070_bib5","doi-asserted-by":"crossref","first-page":"11625","DOI":"10.1074\/jbc.M710288200","article-title":"Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A]","volume":"283","author":"Azam","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111070_bib7","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1074\/jbc.271.13.7522","article-title":"A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors","volume":"271","author":"Cartier","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111070_bib8","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nsmb951","article-title":"Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant","volume":"12","author":"Celie","year":"2005","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"24","key":"10.1016\/j.neuropharm.2026.111070_bib9","doi-asserted-by":"crossref","first-page":"8445","DOI":"10.1523\/JNEUROSCI.23-24-08445.2003","article-title":"Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors","volume":"23","author":"Dowell","year":"2003","journal-title":"J. Neurosci."},{"issue":"29","key":"10.1016\/j.neuropharm.2026.111070_bib10","doi-asserted-by":"crossref","first-page":"9877","DOI":"10.1523\/JNEUROSCI.2056-10.2010","article-title":"Cholinergic modulation of locomotion and striatal dopamine release is mediated by alpha6alpha4* nicotinic acetylcholine receptors","volume":"30","author":"Drenan","year":"2010","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111070_bib11","first-page":"461","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111070_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/026119299702500321","article-title":"Ethical principles and guidelines for scientific experiments on animals","volume":"25","year":"1997","journal-title":"Altern. Lab. Anim."},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.111070_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-2999(03)01540-1","article-title":"Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties","volume":"466","author":"Evans","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.111070_bib14","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1073\/pnas.1103000108","article-title":"Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine","volume":"108","author":"Exley","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.111070_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/978-3-540-30880-5_4","article-title":"Hyperhydroxylation: a new strategy for neuronal targeting by venomous marine molluscs","volume":"43","author":"Franco","year":"2006","journal-title":"Prog. Mol. Subcell. Biol."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.111070_bib17","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1523\/JNEUROSCI.5095-09.2010","article-title":"Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement","volume":"30","author":"Gotti","year":"2010","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111070_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pneurobio.2004.09.006","article-title":"Neuronal nicotinic receptors: from structure to pathology","volume":"74","author":"Gotti","year":"2004","journal-title":"Prog. Neurobiol."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111070_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrc3725","article-title":"Connections of nicotine to cancer","volume":"14","author":"Grando","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.neuropharm.2026.111070_bib19","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1038\/sj.emboj.7600828","article-title":"Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations","volume":"24","author":"Hansen","year":"2005","journal-title":"EMBO J."},{"issue":"35","key":"10.1016\/j.neuropharm.2026.111070_bib21","doi-asserted-by":"crossref","first-page":"25428","DOI":"10.1074\/jbc.M113.482059","article-title":"Positional scanning mutagenesis of \u03b1-conotoxin PeIA identifies critical residues that confer potency and selectivity for \u03b16\/\u03b13\u03b22\u03b23 and \u03b13\u03b22 nicotinic acetylcholine receptors","volume":"288","author":"Hone","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.111070_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1124\/mol.112.080853","article-title":"\u03b1-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks \u03b16\u03b22\u03b23 versus \u03b16\u03b24 nicotinic acetylcholine receptors","volume":"82","author":"Hone","year":"2012","journal-title":"Mol. Pharmacol."},{"issue":"46","key":"10.1016\/j.neuropharm.2026.111070_bib22","doi-asserted-by":"crossref","first-page":"17838","DOI":"10.1074\/jbc.RA118.005649","article-title":"Molecular determinants of \u03b1-conotoxin potency for inhibition of human and rat \u03b16\u03b24 nicotinic acetylcholine receptors","volume":"293","author":"Hone","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111070_bib23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2012.08.012","article-title":"Nicotinic acetylcholine receptors: from basic science to therapeutics","volume":"137","author":"Hurst","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111070_bib24","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejphar.2014.06.005","article-title":"Pharmacological characterisation of \u03b16\u03b24\u2217 nicotinic acetylcholine receptors assembled from three chimeric \u03b16\/\u03b13 subunits in tsA201 cells","volume":"740","author":"Jensen","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111070_bib25","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1096\/fj.12-204487","article-title":"\u03b16 nAChR subunit residues that confer \u03b1-conotoxin BuIA selectivity","volume":"26","author":"Kim","year":"2012","journal-title":"FASEB J."},{"issue":"13","key":"10.1016\/j.neuropharm.2026.111070_bib26","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1016\/S0028-3908(00)00144-1","article-title":"Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses","volume":"39","author":"Kuryatov","year":"2000","journal-title":"Neuropharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2026.111070_bib27","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tins.2004.04.002","article-title":"Cys-loop receptors: new twists and turns","volume":"27","author":"Lester","year":"2004","journal-title":"Trends Neurosci."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111070_bib29","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1096\/fj.13-244103","article-title":"A novel \u03b14\/7-conotoxin LvIA from Conus lividus that selectively blocks \u03b13\u03b22 vs. \u03b16\/\u03b13\u03b22\u03b23 nicotinic acetylcholine receptors","volume":"28","author":"Luo","year":"2014","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.111070_bib28","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1074\/jbc.M112.427898","article-title":"Characterization of a novel \u03b1-conotoxin from conus textile that selectively targets \u03b16\/\u03b13\u03b22\u03b23 nicotinic acetylcholine receptors","volume":"288","author":"Luo","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.111070_bib30","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1124\/mol.65.4.944","article-title":"Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors","volume":"65","author":"Mcintosh","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"34","key":"10.1016\/j.neuropharm.2026.111070_bib31","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M504102200","article-title":"A novel alpha-conotoxin, PeIA, cloned from Conus pergrandis, discriminates between rat alpha9alpha10 and alpha7 nicotinic cholinergic receptors","volume":"280","author":"Mcintosh","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111070_bib32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2008.07.041","article-title":"Diversity of vertebrate nicotinic acetylcholine receptors","volume":"56","author":"Millar","year":"2009","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111070_bib33","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1111\/j.1432-1033.2004.04145.x","article-title":"Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes","volume":"271","author":"Nicke","year":"2004","journal-title":"Eur. J. Biochem."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.111070_bib34","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.bioconjchem.3c00283","article-title":"Synthesis, activity, and application of fluorescent analogs of [D1G, \u039414Q]LvIC targeting \u03b16\u03b24 nicotinic acetylcholine receptor","volume":"34","author":"Pei","year":"2023","journal-title":"Bioconjug. Chem."},{"issue":"17","key":"10.1016\/j.neuropharm.2026.111070_bib35","doi-asserted-by":"crossref","first-page":"17596","DOI":"10.1074\/jbc.M309654200","article-title":"The A-superfamily of conotoxins: structural and functional divergence","volume":"279","author":"Santos","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111070_bib36","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1038\/s41467-025-58333-0","article-title":"Molecular insights into the \u03b16\u03b24 nicotinic acetylcholine receptor function and ligand recognition","volume":"16","author":"Su","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2026.111070_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107691","article-title":"\u03b1-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of \u03b16\u03b24* nicotinic acetylcholine receptors","volume":"157","author":"Van Hout","year":"2019","journal-title":"Neuropharmacology"},{"issue":"287","key":"10.1016\/j.neuropharm.2026.111070_bib39","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009986","article-title":"The nicotinic \u03b16 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2\/3 receptors","volume":"7","author":"Wieskopf","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.111070_bib40","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.3390\/md11093537","article-title":"Optimal cleavage and oxidative folding of \u03b1-conotoxin TxIB as a therapeutic candidate peptide","volume":"11","author":"Wu","year":"2013","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.111070_bib41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3390\/molecules19010966","article-title":"Influence of disulfide connectivity on structure and bioactivity of \u03b1-conotoxin TxIA","volume":"19","author":"Wu","year":"2014","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.neuropharm.2026.111070_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24108618","article-title":"Molecular determinants of species specificity of \u03b1-Conotoxin TxIB towards rat and human \u03b16\/\u03b13\u03b24 nicotinic acetylcholine receptors","volume":"24","author":"Xie","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.111070_bib43","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1523\/JNEUROSCI.3003-10.2011","article-title":"Functional nicotinic acetylcholine receptors containing \u03b16 subunits are on GABAergic neuronal boutons adherent to ventral tegmental area dopamine neurons","volume":"31","author":"Yang","year":"2011","journal-title":"J. Neurosci."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.111070_bib45","article-title":"Molecular mechanisms of \u03b1-conotoxin [S9K]TxID selectively targeting the rat \u03b13\u03b24 nicotinic acetylcholine receptor","volume":"318","author":"Yu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.neuropharm.2026.111070_bib44","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.neuropharm.2018.07.019","article-title":"Species specificity of rat and human \u03b17 nicotinic acetylcholine receptors towards different classes of peptide and protein antagonists","volume":"139","author":"Yu","year":"2018","journal-title":"Neuropharmacology"},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2026.111070_bib46","article-title":"\u03b16 nicotinic acetylcholine receptors: a pharmacological challenge with untapped therapeutic promise","volume":"302","author":"Zhang","year":"2026","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.neuropharm.2026.111070_bib47","doi-asserted-by":"crossref","first-page":"9855","DOI":"10.1074\/jbc.M114.632646","article-title":"Key residues in the nicotinic acetylcholine receptor \u03b22 subunit contribute to \u03b1-conotoxin LvIA binding","volume":"290","author":"Zhangsun","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.111070_bib48","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1021\/acs.jmedchem.2c01786","article-title":"Discovery, characterization, and engineering of LvIC, an \u03b14\/4-Conotoxin that selectively blocks rat \u03b16\/\u03b13\u03b24 nicotinic acetylcholine receptors","volume":"66","author":"Zhu","year":"2023","journal-title":"J. Med. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826002443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:33:21Z","timestamp":1783456401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826002443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":46,"alternative-id":["S0028390826002443"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111070","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of key determinants in \u03b1 subunit for \u03b1-conotoxin [D1G, \u0394Q14]LvIC selectively targeting rat \u03b16\/\u03b13\u03b24 nicotinic acetylcholine receptor","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111070"}}